It is an innovative therapeutic approach used primarily for treatment-resistant depression.

At low doses, ketamine acts quickly on the neural circuits involved in mood regulation, promoting neuroplasticity and helping individuals regain control over their mental health.

• Intravenous (IV) – mandatory for the first session to monitor response and tolerance.

• Intramuscular (IM) – used in follow-up once tolerance is well established.

• Sublingual (SL) – a non-invasive option often offered at home under nursing supervision.

Adults living with:

• Major depression resistant to conventional treatments

• Bipolar disorder (depressive phase)

• Post-traumatic stress disorder (PTSD)

• Obsessive-compulsive disorder (OCD)

Each patient is individually assessed by our team.

Because it can produce rapid symptom improvement, often within the first 24 to 72 hours, which can be crucial for patients in suicidal crisis or at a therapeutic impasse.

An initial protocol generally includes 6 sessions over 2 to 3 weeks.

A maintenance treatment plan is then proposed based on observed effects and clinical goals.

The most common are:

• Dissociation (feeling of disconnection)

• Temporary increase in blood pressure

• Nausea or dizziness

• Temporary anxiety

At NeuroSoins, we manage these effects in-clinic to ensure a safe and positive experience.

Yes, when administered in a professional setting with a complete clinical evaluation, medical supervision, and clear protocols such as those used at NeuroSoins.

The risk is low at therapeutic doses in a monitored medical setting.

We provide ongoing follow-up to detect any potential misuse.

Yes, after an initial series of in-clinic treatments, certain administrations (IM or SL) can be offered at home under nursing supervision and after a safety assessment.

Ketamine is considered an emerging treatment. Some private insurance plans may offer partial reimbursement.

We provide receipts for your claim submissions.

Yes. According to INESSS, ketamine is a special-access treatment for refractory depression and must be used in a rigorous clinical setting with medical follow-up.

The treatment is prescribed by Dr. Hani Iskandar, a psychiatrist specializing in treatment-resistant depression, with over 35 years of experience. The evaluation is carried out in collaboration with a clinical nurse.

We use:

• Validated clinical questionnaires

• Observations during and after the session

• Patient discussions on their emotional, cognitive, and physical experience

Absolutely. Our approach is holistic and may include:

• Guided meditation

• Conscious breathing

• Therapeutic journaling

• Hypnotherapy

• Psychological support

Book an appointment for an initial evaluation.

Together, we will determine if you are a good candidate and create a personalized therapeutic plan tailored to your needs.